Former CFO Marc Wilson transitions to consultant role through April 2026

Crinetics Pharmaceuticals, Inc.

Wilson resigned as employee on April 1, 2025, and entered a consulting agreement through April 1, 2026, with a possible six-month extension.
He will receive $300 per hour for services plus reimbursement of reasonable out-of-pocket expenses.
Outstanding equity awards continue vesting during consulting period; accelerates upon termination without cause, death, disability, or change in control.
The agreement includes a general release of claims against the company.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Marc Wilson

Other

CRNX · Crinetics Pharmaceuticals, Inc.

Effective: 2025-04-01
Filed: April 4, 2025, 7:59 PM ET

pursuant to which Mr. Wilson resigned as an employee of the Company, effective April 1, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marc Wilson resigned as other at Crinetics Pharmaceuticals, Inc..

Action: resigned

Exact text from the filing

pursuant to which Mr. Wilson resigned as an employee of the Company, effective April 1, 2025

View on SEC.gov

Crinetics Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-051179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.